Skip to main content
. 2010 Dec 17;4(3):211–218. doi: 10.1007/s12349-010-0045-4

Table 3.

Outcome of treatment with Cyracos® at endpoint using the CGI-I scale for determination of clinical improvement of anxiety and insomnia symptoms

Outcome Anxiety Insomnia
n % n %
Responder 19 95 20 100
Nonresponder 1 5 0 0
 Very much improved 14 70 17 85
 Much improved 5 25 3 15
 Minimally improved 1 5 0 0
 No change 0 0 0 0
 Minimally worse 0 0 0
 Much worse 0 0 0 0
 Very much worse 0 0 0 0